Publications

Letter Comment Ppublish

PubMed: 42308491 DOI: 10.1056/NEJMc2605751

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Reply.

N Engl J Med 394(23):2383

Authors: Christof Vulsteke, Anders Ullén

Affiliations

  • AZ Maria Middelares, Ghent, Belgium.
  • Karolinska University Hospital, Stockholm.

MeSH

Urinary Bladder, Urinary Bladder Neoplasms, Neoplasms